Transverse myelitis following hepatitis B vaccination. 1993

F Trevisani, and G C Gattinara, and P Caraceni, and M Bernardi, and F Albertoni, and R D'Alessandro, and L Elia, and G Gasbarrini

UI MeSH Term Description Entries
D009188 Myelitis, Transverse Inflammation of a transverse portion of the spinal cord characterized by acute or subacute segmental demyelination or necrosis. The condition may occur sporadically, follow an infection or vaccination, or present as a paraneoplastic syndrome (see also ENCEPHALOMYELITIS, ACUTE DISSEMINATED). Clinical manifestations include motor weakness, sensory loss, and incontinence. (Adams et al., Principles of Neurology, 6th ed, pp1242-6) Demyelinative Myelitis,Transverse Myelitis,Myelitis, Acute Transverse,Myelitis, Necrotizing,Myelitis, Paraneoplastic,Myelitis, Postinfectious,Myelitis, Postvaccinal,Myelitis, Subacute Transverse,Postinfectious Myelitis,Transverse Myelopathy Syndrome,Acute Transverse Myelitis,Myelitides, Subacute Transverse,Myelitis, Demyelinative,Necrotizing Myelitis,Paraneoplastic Myelitis,Postvaccinal Myelitis,Subacute Transverse Myelitis,Transverse Myelitis, Acute,Transverse Myelitis, Subacute,Transverse Myelopathy Syndromes
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D017325 Hepatitis B Vaccines Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced. Hepatitis B Vaccine,Vaccine, Hepatitis B,Vaccines, Hepatitis B

Related Publications

F Trevisani, and G C Gattinara, and P Caraceni, and M Bernardi, and F Albertoni, and R D'Alessandro, and L Elia, and G Gasbarrini
January 2000, Revista de neurologia,
F Trevisani, and G C Gattinara, and P Caraceni, and M Bernardi, and F Albertoni, and R D'Alessandro, and L Elia, and G Gasbarrini
January 1999, Presse medicale (Paris, France : 1983),
F Trevisani, and G C Gattinara, and P Caraceni, and M Bernardi, and F Albertoni, and R D'Alessandro, and L Elia, and G Gasbarrini
June 1954, Acta neurologica et psychiatrica Belgica,
F Trevisani, and G C Gattinara, and P Caraceni, and M Bernardi, and F Albertoni, and R D'Alessandro, and L Elia, and G Gasbarrini
December 2012, Autoimmunity reviews,
F Trevisani, and G C Gattinara, and P Caraceni, and M Bernardi, and F Albertoni, and R D'Alessandro, and L Elia, and G Gasbarrini
June 2003, Arquivos de neuro-psiquiatria,
F Trevisani, and G C Gattinara, and P Caraceni, and M Bernardi, and F Albertoni, and R D'Alessandro, and L Elia, and G Gasbarrini
January 2007, The Ulster medical journal,
F Trevisani, and G C Gattinara, and P Caraceni, and M Bernardi, and F Albertoni, and R D'Alessandro, and L Elia, and G Gasbarrini
January 2022, NMC case report journal,
F Trevisani, and G C Gattinara, and P Caraceni, and M Bernardi, and F Albertoni, and R D'Alessandro, and L Elia, and G Gasbarrini
September 2021, Vaccines,
F Trevisani, and G C Gattinara, and P Caraceni, and M Bernardi, and F Albertoni, and R D'Alessandro, and L Elia, and G Gasbarrini
June 1971, JAMA,
F Trevisani, and G C Gattinara, and P Caraceni, and M Bernardi, and F Albertoni, and R D'Alessandro, and L Elia, and G Gasbarrini
October 1990, Journal of the Royal Society of Medicine,
Copied contents to your clipboard!